Is CimaVax EGF Available in Germany?
Cancer is one of the illnesses that every individual is afraid to have since the possibility to be free from this illness is not that big. There are several kinds of cancer everyone can suffer from, specifically if not treated right away. One of which is the lung cancer. This type of cancer occurs especially to people who keeps on smoking or those who have been exposed to this activity. Even second-hand smokers have high chance of acquiring lung cancer.
CimaVax EGF is the first-ever developed vaccine which main target is the non-small-cell lung carcinoma found in lung cancer. The vaccine developed in Cuba and was the outcome of the 25 years conducted research project conducted by the Cuba’s Center of Molecular Immunology.
CimaVax EGF has gone through two trials and is now on the process for its third trial. The next trial that will be done are in arguments on which country should it be tested. Some of the countries that are being talked for the trial are United States, European countries, and Japan. Furthermore, the vaccine will target the epidermal growth factor (EFG) which is a protein.
CimaVax EGF is only available in Cuba. It has not yet reached other countries like Germany. The CimaVax EGF together with other vaccines is being tested in United States. As the vaccine was used, it gave mild side effects that are tolerable. Some of which are fever, chills and feeling sick.
When the trial for the vaccine has been conducted, some of the people who received the vaccine were able to live longer for four to six months. As the trial has been finished, the vaccine was perfect for people ages 60 and below. Since 2011, the vaccine has been free to all the patients and has already helped 5,000 patients in all parts of the world.
CimaVax EGF is now in the trial process in different countries such as Peru, UK, China and Canada while it is only waiting for the process of approval in Colombia, Paraguay, Argentina and Brazil. The vaccine may not be available in Germany but time will come that the trial and approval process will also be conducted in Germany.
CimaVax EGF is the vaccine that will slow down the spread of cancer cells in the body. The vaccine that has been developed in Cuba is one of the hopes for lung cancer.